Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dementia | 85 | 2024 | 2741 | 14.840 |
Why?
|
Netherlands | 101 | 2024 | 2277 | 8.850 |
Why?
|
Gait | 11 | 2020 | 823 | 3.710 |
Why?
|
Population Surveillance | 23 | 2021 | 2594 | 3.480 |
Why?
|
Alzheimer Disease | 39 | 2024 | 8715 | 3.130 |
Why?
|
Cognition | 37 | 2024 | 7057 | 2.980 |
Why?
|
Brain | 56 | 2024 | 27158 | 2.860 |
Why?
|
Stroke | 45 | 2024 | 9744 | 2.600 |
Why?
|
Cognition Disorders | 18 | 2022 | 3967 | 2.560 |
Why?
|
Polyneuropathies | 5 | 2023 | 139 | 2.510 |
Why?
|
Parkinsonian Disorders | 6 | 2019 | 285 | 2.470 |
Why?
|
Aged | 207 | 2024 | 171344 | 2.350 |
Why?
|
Genome-Wide Association Study | 49 | 2024 | 12808 | 2.320 |
Why?
|
Dementia, Vascular | 5 | 2019 | 126 | 2.220 |
Why?
|
Parkinson Disease | 14 | 2024 | 2884 | 2.120 |
Why?
|
Life Expectancy | 5 | 2021 | 1248 | 2.010 |
Why?
|
Neurofilament Proteins | 3 | 2024 | 335 | 1.980 |
Why?
|
Risk Factors | 113 | 2024 | 74889 | 1.920 |
Why?
|
Activities of Daily Living | 8 | 2017 | 2429 | 1.910 |
Why?
|
Magnetic Resonance Imaging | 62 | 2024 | 36570 | 1.770 |
Why?
|
Cerebrovascular Circulation | 9 | 2024 | 2671 | 1.740 |
Why?
|
Cohort Studies | 77 | 2024 | 41706 | 1.700 |
Why?
|
Male | 214 | 2024 | 364154 | 1.690 |
Why?
|
Middle Aged | 166 | 2024 | 223267 | 1.680 |
Why?
|
Female | 215 | 2024 | 396532 | 1.600 |
Why?
|
Aging | 20 | 2024 | 8728 | 1.600 |
Why?
|
Blood Pressure | 13 | 2024 | 8533 | 1.590 |
Why?
|
Aged, 80 and over | 86 | 2024 | 59548 | 1.580 |
Why?
|
Epidemiologic Research Design | 4 | 2021 | 368 | 1.560 |
Why?
|
Genetic Predisposition to Disease | 42 | 2024 | 18076 | 1.550 |
Why?
|
Prospective Studies | 67 | 2024 | 54872 | 1.490 |
Why?
|
Retinal Vessels | 6 | 2017 | 863 | 1.490 |
Why?
|
Humans | 295 | 2024 | 766812 | 1.470 |
Why?
|
Neuropsychological Tests | 29 | 2024 | 7119 | 1.460 |
Why?
|
Cerebrovascular Disorders | 8 | 2024 | 1478 | 1.440 |
Why?
|
Cerebral Arteries | 5 | 2018 | 490 | 1.350 |
Why?
|
Atherosclerosis | 8 | 2023 | 3421 | 1.270 |
Why?
|
Community Health Planning | 10 | 2019 | 164 | 1.270 |
Why?
|
Cognitive Reserve | 3 | 2020 | 92 | 1.210 |
Why?
|
Independent Living | 6 | 2024 | 584 | 1.190 |
Why?
|
Motor Skills | 4 | 2021 | 519 | 1.180 |
Why?
|
Apolipoproteins E | 11 | 2023 | 1459 | 1.160 |
Why?
|
Cardiovascular Diseases | 24 | 2024 | 15652 | 1.150 |
Why?
|
Longitudinal Studies | 30 | 2024 | 14762 | 1.080 |
Why?
|
Neurodegenerative Diseases | 5 | 2024 | 1089 | 1.070 |
Why?
|
Brain Infarction | 4 | 2019 | 285 | 1.060 |
Why?
|
Hippocampus | 10 | 2022 | 3776 | 1.050 |
Why?
|
Polymorphism, Single Nucleotide | 39 | 2024 | 16044 | 1.050 |
Why?
|
Follow-Up Studies | 39 | 2024 | 39312 | 1.000 |
Why?
|
Microvessels | 3 | 2017 | 586 | 0.990 |
Why?
|
Ischemic Attack, Transient | 3 | 2016 | 874 | 0.990 |
Why?
|
Amyloid beta-Peptides | 8 | 2024 | 3886 | 0.980 |
Why?
|
Brain Ischemia | 11 | 2016 | 3001 | 0.960 |
Why?
|
Incidence | 28 | 2024 | 21527 | 0.960 |
Why?
|
Hypertension | 14 | 2024 | 8616 | 0.960 |
Why?
|
Cross-Sectional Studies | 38 | 2024 | 26309 | 0.930 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 5 | 2022 | 3246 | 0.920 |
Why?
|
Gait Disorders, Neurologic | 2 | 2017 | 244 | 0.900 |
Why?
|
Akinetic Mutism | 1 | 2023 | 11 | 0.890 |
Why?
|
Situs Inversus | 1 | 2023 | 63 | 0.870 |
Why?
|
Baroreflex | 1 | 2024 | 154 | 0.870 |
Why?
|
Churg-Strauss Syndrome | 1 | 2023 | 75 | 0.840 |
Why?
|
Myoclonus | 1 | 2023 | 107 | 0.840 |
Why?
|
Genetic Variation | 11 | 2024 | 6613 | 0.840 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2023 | 92 | 0.830 |
Why?
|
Migraine Disorders | 5 | 2024 | 1710 | 0.830 |
Why?
|
Atrial Fibrillation | 8 | 2024 | 5182 | 0.810 |
Why?
|
Bone Diseases, Metabolic | 2 | 2023 | 407 | 0.810 |
Why?
|
MicroRNAs | 8 | 2024 | 3789 | 0.810 |
Why?
|
Coffee | 3 | 2016 | 594 | 0.810 |
Why?
|
tau Proteins | 4 | 2024 | 2106 | 0.800 |
Why?
|
Molecular Epidemiology | 2 | 2015 | 473 | 0.780 |
Why?
|
Nitrates | 1 | 2023 | 259 | 0.780 |
Why?
|
Mortality | 3 | 2024 | 2908 | 0.760 |
Why?
|
Calcinosis | 3 | 2017 | 1480 | 0.760 |
Why?
|
Resistin | 1 | 2022 | 174 | 0.750 |
Why?
|
Carotid Artery Diseases | 3 | 2023 | 872 | 0.750 |
Why?
|
Accidental Falls | 3 | 2018 | 1077 | 0.730 |
Why?
|
Proportional Hazards Models | 18 | 2024 | 12536 | 0.720 |
Why?
|
Genetic Loci | 12 | 2024 | 2631 | 0.720 |
Why?
|
Chromosomes, Human, Pair 17 | 3 | 2012 | 418 | 0.710 |
Why?
|
Clinical Medicine | 1 | 2022 | 145 | 0.710 |
Why?
|
Intracranial Arteriosclerosis | 3 | 2023 | 138 | 0.710 |
Why?
|
Nerve Fibers, Myelinated | 6 | 2013 | 951 | 0.700 |
Why?
|
Smoking | 9 | 2024 | 9077 | 0.690 |
Why?
|
Arteriosclerosis | 2 | 2024 | 1055 | 0.690 |
Why?
|
Atrophy | 8 | 2024 | 1631 | 0.680 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2232 | 0.670 |
Why?
|
Spirometry | 2 | 2021 | 929 | 0.660 |
Why?
|
Risk | 13 | 2018 | 9602 | 0.640 |
Why?
|
Comorbidity | 12 | 2021 | 10580 | 0.630 |
Why?
|
von Willebrand Factor | 2 | 2024 | 680 | 0.620 |
Why?
|
Intracranial Hemorrhages | 2 | 2014 | 810 | 0.620 |
Why?
|
Risk Assessment | 21 | 2024 | 24299 | 0.620 |
Why?
|
Carcinoembryonic Antigen | 1 | 2020 | 338 | 0.610 |
Why?
|
Sex Factors | 13 | 2024 | 10619 | 0.590 |
Why?
|
Vegetables | 1 | 2023 | 1199 | 0.580 |
Why?
|
Chronic Disease | 5 | 2020 | 9358 | 0.580 |
Why?
|
Herpes Simplex | 1 | 2021 | 470 | 0.580 |
Why?
|
Chromosomes, Human, Pair 12 | 4 | 2014 | 432 | 0.570 |
Why?
|
Polypharmacy | 1 | 2020 | 307 | 0.570 |
Why?
|
Executive Function | 5 | 2023 | 1396 | 0.560 |
Why?
|
Parturition | 1 | 2021 | 453 | 0.560 |
Why?
|
Organ Size | 9 | 2024 | 2262 | 0.560 |
Why?
|
Granulocytes | 1 | 2019 | 551 | 0.550 |
Why?
|
Longevity | 1 | 2024 | 1083 | 0.550 |
Why?
|
Disease Progression | 12 | 2024 | 13642 | 0.540 |
Why?
|
Venules | 2 | 2016 | 161 | 0.540 |
Why?
|
Diabetes Mellitus | 6 | 2024 | 5888 | 0.540 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2019 | 8928 | 0.530 |
Why?
|
Actigraphy | 1 | 2020 | 526 | 0.520 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2015 | 1750 | 0.520 |
Why?
|
Genotype | 15 | 2024 | 13036 | 0.520 |
Why?
|
Causality | 3 | 2021 | 1252 | 0.520 |
Why?
|
Arterioles | 2 | 2016 | 252 | 0.510 |
Why?
|
Occupations | 1 | 2018 | 516 | 0.510 |
Why?
|
Cerebral Cortex | 5 | 2024 | 5753 | 0.510 |
Why?
|
Cerebellum | 2 | 2014 | 1520 | 0.510 |
Why?
|
Models, Statistical | 4 | 2019 | 5092 | 0.510 |
Why?
|
Prevalence | 15 | 2024 | 15835 | 0.500 |
Why?
|
Nervous System Diseases | 3 | 2018 | 1659 | 0.500 |
Why?
|
Herpesvirus 1, Human | 1 | 2021 | 743 | 0.500 |
Why?
|
Aorta, Thoracic | 4 | 2024 | 1110 | 0.490 |
Why?
|
Apolipoprotein E4 | 8 | 2023 | 709 | 0.490 |
Why?
|
Depression | 6 | 2024 | 8225 | 0.480 |
Why?
|
Magnesium | 2 | 2021 | 815 | 0.480 |
Why?
|
Cerebral Hemorrhage | 6 | 2023 | 2654 | 0.480 |
Why?
|
Helicobacter pylori | 1 | 2018 | 380 | 0.470 |
Why?
|
Immunity | 1 | 2020 | 1002 | 0.470 |
Why?
|
Helicobacter Infections | 1 | 2018 | 390 | 0.470 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2012 | 370 | 0.450 |
Why?
|
Functional Laterality | 3 | 2016 | 2244 | 0.450 |
Why?
|
Brain Edema | 1 | 2018 | 601 | 0.450 |
Why?
|
Anxiety Disorders | 2 | 2016 | 2743 | 0.440 |
Why?
|
Educational Status | 5 | 2021 | 2510 | 0.430 |
Why?
|
Telomere | 1 | 2020 | 943 | 0.430 |
Why?
|
Hemoglobins | 1 | 2019 | 1531 | 0.420 |
Why?
|
Hearing Loss | 1 | 2020 | 785 | 0.420 |
Why?
|
Statistics as Topic | 1 | 2019 | 2350 | 0.420 |
Why?
|
Vasomotor System | 1 | 2013 | 208 | 0.420 |
Why?
|
Carotid Artery, Internal | 1 | 2015 | 440 | 0.420 |
Why?
|
Thyrotropin | 1 | 2016 | 834 | 0.410 |
Why?
|
Thyroxine | 1 | 2016 | 665 | 0.410 |
Why?
|
Renal Insufficiency | 1 | 2018 | 811 | 0.410 |
Why?
|
Intracranial Hemorrhage, Hypertensive | 1 | 2012 | 19 | 0.410 |
Why?
|
Cause of Death | 4 | 2024 | 3717 | 0.410 |
Why?
|
Walking | 2 | 2017 | 1201 | 0.410 |
Why?
|
Pathology, Molecular | 1 | 2015 | 329 | 0.400 |
Why?
|
Neoplasms | 6 | 2024 | 22350 | 0.400 |
Why?
|
Air Pollution | 2 | 2024 | 2377 | 0.400 |
Why?
|
Peptide Fragments | 2 | 2015 | 5143 | 0.400 |
Why?
|
Age Factors | 9 | 2024 | 18397 | 0.390 |
Why?
|
Extracellular Fluid | 1 | 2013 | 165 | 0.390 |
Why?
|
Diabetic Neuropathies | 1 | 2015 | 409 | 0.380 |
Why?
|
Restless Legs Syndrome | 1 | 2015 | 235 | 0.380 |
Why?
|
Axons | 1 | 2019 | 1675 | 0.380 |
Why?
|
Vasodilation | 1 | 2015 | 968 | 0.380 |
Why?
|
Leukoencephalopathies | 2 | 2011 | 258 | 0.380 |
Why?
|
Kidney Diseases | 3 | 2015 | 2101 | 0.380 |
Why?
|
Receptor, IGF Type 1 | 1 | 2014 | 385 | 0.370 |
Why?
|
Regional Blood Flow | 2 | 2012 | 1478 | 0.370 |
Why?
|
Carotid Arteries | 4 | 2019 | 932 | 0.370 |
Why?
|
Research Design | 3 | 2022 | 6206 | 0.370 |
Why?
|
Lymphocytes | 1 | 2019 | 2606 | 0.370 |
Why?
|
Cholesterol | 4 | 2023 | 2904 | 0.360 |
Why?
|
Beverages | 1 | 2016 | 819 | 0.360 |
Why?
|
Air Pollutants | 3 | 2024 | 2919 | 0.350 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2024 | 2902 | 0.350 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1725 | 0.350 |
Why?
|
Disability Evaluation | 2 | 2014 | 1828 | 0.340 |
Why?
|
Hyperuricemia | 1 | 2013 | 222 | 0.340 |
Why?
|
Prognosis | 12 | 2022 | 29959 | 0.340 |
Why?
|
Health Personnel | 1 | 2024 | 3384 | 0.340 |
Why?
|
Anemia | 1 | 2019 | 1514 | 0.330 |
Why?
|
Prediabetic State | 1 | 2015 | 547 | 0.330 |
Why?
|
Aortic Diseases | 1 | 2015 | 741 | 0.330 |
Why?
|
Creatinine | 1 | 2015 | 1917 | 0.330 |
Why?
|
Mental Status Schedule | 3 | 2018 | 315 | 0.330 |
Why?
|
Blood Platelets | 2 | 2024 | 2465 | 0.330 |
Why?
|
Coronary Disease | 2 | 2022 | 5915 | 0.330 |
Why?
|
Basilar Artery | 3 | 2024 | 207 | 0.320 |
Why?
|
Health Status Indicators | 1 | 2014 | 968 | 0.320 |
Why?
|
Data Interpretation, Statistical | 3 | 2015 | 2694 | 0.320 |
Why?
|
Antihypertensive Agents | 4 | 2024 | 2030 | 0.320 |
Why?
|
Vascular Diseases | 1 | 2017 | 1161 | 0.310 |
Why?
|
Circadian Rhythm | 1 | 2020 | 2590 | 0.310 |
Why?
|
Diffusion Tensor Imaging | 2 | 2016 | 2419 | 0.310 |
Why?
|
Health Education | 1 | 2015 | 1060 | 0.310 |
Why?
|
Mendelian Randomization Analysis | 5 | 2024 | 1044 | 0.300 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1145 | 0.300 |
Why?
|
Aortic Valve | 2 | 2024 | 1966 | 0.300 |
Why?
|
Nerve Net | 1 | 2020 | 2307 | 0.300 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5795 | 0.300 |
Why?
|
Brain Mapping | 3 | 2019 | 6597 | 0.290 |
Why?
|
Cost of Illness | 2 | 2015 | 1949 | 0.290 |
Why?
|
Age Distribution | 4 | 2016 | 2869 | 0.290 |
Why?
|
Predictive Value of Tests | 8 | 2020 | 15425 | 0.290 |
Why?
|
Memory Disorders | 1 | 2014 | 1193 | 0.290 |
Why?
|
Residence Characteristics | 4 | 2024 | 2116 | 0.280 |
Why?
|
Early Diagnosis | 3 | 2020 | 1186 | 0.270 |
Why?
|
Nerve Tissue Proteins | 4 | 2024 | 4401 | 0.270 |
Why?
|
Polymorphism, Genetic | 3 | 2017 | 4249 | 0.270 |
Why?
|
Diet | 4 | 2023 | 8088 | 0.270 |
Why?
|
Cerebral Infarction | 4 | 2012 | 968 | 0.260 |
Why?
|
Temporal Lobe | 1 | 2014 | 1716 | 0.260 |
Why?
|
Quantitative Trait Loci | 2 | 2024 | 2133 | 0.260 |
Why?
|
Severity of Illness Index | 5 | 2016 | 15912 | 0.260 |
Why?
|
Intermediate Filaments | 2 | 2023 | 171 | 0.260 |
Why?
|
Coronary Artery Disease | 7 | 2024 | 6575 | 0.250 |
Why?
|
Lung | 2 | 2022 | 10068 | 0.250 |
Why?
|
Intracranial Aneurysm | 1 | 2015 | 1271 | 0.250 |
Why?
|
Diabetes Complications | 1 | 2012 | 1319 | 0.250 |
Why?
|
Seasons | 2 | 2021 | 1519 | 0.250 |
Why?
|
Genetic Markers | 7 | 2015 | 2603 | 0.250 |
Why?
|
Vital Capacity | 2 | 2021 | 995 | 0.240 |
Why?
|
Fibrosis | 2 | 2023 | 2078 | 0.240 |
Why?
|
Psychomotor Performance | 3 | 2019 | 1885 | 0.240 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2019 | 2809 | 0.240 |
Why?
|
Linear Models | 5 | 2016 | 5873 | 0.240 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2012 | 887 | 0.240 |
Why?
|
Kininogens | 1 | 2024 | 15 | 0.230 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2513 | 0.230 |
Why?
|
Sleep | 1 | 2020 | 4814 | 0.230 |
Why?
|
DNA Replication | 1 | 2011 | 1426 | 0.230 |
Why?
|
Aortic Valve Stenosis | 1 | 2017 | 2023 | 0.230 |
Why?
|
Age of Onset | 5 | 2019 | 3343 | 0.230 |
Why?
|
Memory | 4 | 2024 | 2192 | 0.230 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20146 | 0.230 |
Why?
|
Insulin | 2 | 2023 | 6608 | 0.230 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12246 | 0.220 |
Why?
|
Hostility | 1 | 2024 | 185 | 0.220 |
Why?
|
Population | 2 | 2016 | 140 | 0.220 |
Why?
|
Geriatric Assessment | 3 | 2019 | 1422 | 0.220 |
Why?
|
Sural Nerve | 2 | 2023 | 105 | 0.220 |
Why?
|
Biomedical Research | 2 | 2024 | 3459 | 0.220 |
Why?
|
Head | 2 | 2024 | 926 | 0.210 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2306 | 0.210 |
Why?
|
Methylamines | 1 | 2024 | 136 | 0.210 |
Why?
|
Albuminuria | 2 | 2018 | 659 | 0.210 |
Why?
|
Digoxin | 1 | 2024 | 246 | 0.210 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.210 |
Why?
|
Motor Activity | 1 | 2013 | 2711 | 0.210 |
Why?
|
Cell Adhesion Molecules | 2 | 2024 | 1612 | 0.200 |
Why?
|
Marital Status | 1 | 2024 | 426 | 0.200 |
Why?
|
Adult | 24 | 2024 | 223305 | 0.200 |
Why?
|
Membrane Proteins | 4 | 2014 | 7869 | 0.200 |
Why?
|
Exercise | 3 | 2021 | 5945 | 0.200 |
Why?
|
Multiple Sclerosis | 2 | 2016 | 3229 | 0.200 |
Why?
|
Genetic Association Studies | 3 | 2024 | 2744 | 0.200 |
Why?
|
Neural Conduction | 1 | 2023 | 442 | 0.200 |
Why?
|
Bone Density | 3 | 2023 | 3491 | 0.190 |
Why?
|
Factor VIII | 1 | 2024 | 349 | 0.190 |
Why?
|
Sex Characteristics | 3 | 2024 | 2645 | 0.190 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 8045 | 0.190 |
Why?
|
Particulate Matter | 2 | 2024 | 2621 | 0.190 |
Why?
|
Case-Control Studies | 10 | 2021 | 22248 | 0.190 |
Why?
|
Sex Distribution | 3 | 2016 | 2274 | 0.190 |
Why?
|
Time Factors | 8 | 2024 | 40149 | 0.190 |
Why?
|
Coronary Vessels | 3 | 2022 | 3115 | 0.190 |
Why?
|
Europe | 5 | 2021 | 3430 | 0.180 |
Why?
|
Lectins, C-Type | 1 | 2024 | 592 | 0.180 |
Why?
|
Anxiety | 2 | 2024 | 4668 | 0.180 |
Why?
|
Unconsciousness | 1 | 2022 | 252 | 0.180 |
Why?
|
Immunoglobulin G | 3 | 2023 | 4559 | 0.180 |
Why?
|
Lipids | 1 | 2011 | 3322 | 0.170 |
Why?
|
Absorptiometry, Photon | 2 | 2023 | 1707 | 0.170 |
Why?
|
Adipokines | 1 | 2022 | 308 | 0.170 |
Why?
|
Pandemics | 4 | 2024 | 8734 | 0.170 |
Why?
|
Depressive Disorder | 1 | 2012 | 3715 | 0.170 |
Why?
|
Parent-Child Relations | 1 | 2024 | 772 | 0.170 |
Why?
|
Thyroid Gland | 2 | 2016 | 1170 | 0.170 |
Why?
|
Vehicle Emissions | 1 | 2024 | 651 | 0.170 |
Why?
|
Metabolomics | 3 | 2024 | 1674 | 0.170 |
Why?
|
Odds Ratio | 7 | 2018 | 9661 | 0.170 |
Why?
|
Alcohol Drinking | 1 | 2012 | 4045 | 0.160 |
Why?
|
Survival Analysis | 3 | 2018 | 10101 | 0.160 |
Why?
|
Multifactorial Inheritance | 2 | 2024 | 1425 | 0.160 |
Why?
|
Meta-Analysis as Topic | 6 | 2020 | 1365 | 0.160 |
Why?
|
Craniosynostoses | 1 | 2023 | 415 | 0.160 |
Why?
|
Vitamin B 12 | 1 | 2022 | 531 | 0.160 |
Why?
|
Phenotype | 7 | 2024 | 16722 | 0.160 |
Why?
|
Sarcopenia | 1 | 2024 | 378 | 0.160 |
Why?
|
Insulin Resistance | 1 | 2012 | 3989 | 0.150 |
Why?
|
Environmental Exposure | 2 | 2024 | 4544 | 0.150 |
Why?
|
Epistasis, Genetic | 2 | 2010 | 353 | 0.150 |
Why?
|
Neurologic Examination | 2 | 2023 | 913 | 0.150 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 472 | 0.150 |
Why?
|
Serum | 1 | 2019 | 206 | 0.150 |
Why?
|
Benzodiazepines | 1 | 2024 | 1137 | 0.150 |
Why?
|
Blood Cell Count | 1 | 2019 | 405 | 0.150 |
Why?
|
Myocardial Infarction | 4 | 2013 | 11514 | 0.140 |
Why?
|
F Factor | 1 | 2017 | 12 | 0.140 |
Why?
|
Colorimetry | 1 | 2017 | 147 | 0.140 |
Why?
|
Aryldialkylphosphatase | 1 | 2017 | 64 | 0.140 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1198 | 0.140 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2017 | 93 | 0.140 |
Why?
|
Anticoagulants | 1 | 2012 | 4854 | 0.130 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 163 | 0.130 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2017 | 77 | 0.130 |
Why?
|
Eating | 1 | 2023 | 1539 | 0.130 |
Why?
|
Alleles | 3 | 2019 | 6896 | 0.130 |
Why?
|
Action Potentials | 2 | 2024 | 1835 | 0.130 |
Why?
|
Adiponectin | 1 | 2022 | 1121 | 0.130 |
Why?
|
Clusterin | 1 | 2016 | 72 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 1 | 2024 | 1567 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 2018 | 181 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 3 | 2015 | 6514 | 0.130 |
Why?
|
Retinal Vein | 1 | 2015 | 46 | 0.130 |
Why?
|
RNA, Untranslated | 1 | 2019 | 455 | 0.130 |
Why?
|
Parkinson Disease, Secondary | 1 | 2016 | 120 | 0.130 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2015 | 277 | 0.130 |
Why?
|
Syndrome | 1 | 2022 | 3271 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 5 | 2024 | 20710 | 0.120 |
Why?
|
Body Mass Index | 4 | 2024 | 13050 | 0.120 |
Why?
|
Antiporters | 1 | 2016 | 275 | 0.120 |
Why?
|
Retinal Artery | 1 | 2015 | 109 | 0.120 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2016 | 6020 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2024 | 2815 | 0.120 |
Why?
|
Fatty Liver | 1 | 2021 | 810 | 0.120 |
Why?
|
Migraine without Aura | 1 | 2015 | 81 | 0.120 |
Why?
|
Inflammation | 4 | 2024 | 10863 | 0.110 |
Why?
|
Leptin | 1 | 2022 | 1596 | 0.110 |
Why?
|
Receptors, GABA-A | 1 | 2018 | 624 | 0.110 |
Why?
|
Cystatin C | 1 | 2015 | 272 | 0.110 |
Why?
|
Aortography | 1 | 2015 | 423 | 0.110 |
Why?
|
Denmark | 1 | 2016 | 777 | 0.110 |
Why?
|
Preventive Medicine | 1 | 2015 | 246 | 0.110 |
Why?
|
Chromosomes, Human | 2 | 2015 | 437 | 0.110 |
Why?
|
DNA Methylation | 2 | 2024 | 4427 | 0.110 |
Why?
|
Lumbar Vertebrae | 1 | 2023 | 1878 | 0.110 |
Why?
|
Hypotension, Orthostatic | 1 | 2016 | 258 | 0.110 |
Why?
|
Skin | 2 | 2024 | 4499 | 0.110 |
Why?
|
Carotid Artery, Common | 1 | 2014 | 172 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7841 | 0.110 |
Why?
|
Kidney Function Tests | 1 | 2015 | 685 | 0.100 |
Why?
|
Migraine with Aura | 1 | 2015 | 203 | 0.100 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.100 |
Why?
|
Anisotropy | 1 | 2016 | 1286 | 0.100 |
Why?
|
Brain Stem Infarctions | 1 | 2012 | 31 | 0.100 |
Why?
|
Endothelium, Vascular | 1 | 2024 | 4424 | 0.100 |
Why?
|
Pericardium | 1 | 2017 | 681 | 0.100 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 646 | 0.100 |
Why?
|
Antibodies, Bacterial | 1 | 2018 | 1477 | 0.100 |
Why?
|
Neurofibrillary Tangles | 1 | 2014 | 457 | 0.100 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1549 | 0.100 |
Why?
|
Neural Stem Cells | 1 | 2019 | 895 | 0.100 |
Why?
|
Parents | 3 | 2024 | 3592 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2903 | 0.100 |
Why?
|
Leukocytes | 1 | 2020 | 2034 | 0.100 |
Why?
|
Microtubule-Associated Proteins | 1 | 2017 | 1073 | 0.090 |
Why?
|
Computational Biology | 2 | 2024 | 3564 | 0.090 |
Why?
|
Hypolipidemic Agents | 1 | 2016 | 609 | 0.090 |
Why?
|
Receptor, EphA1 | 1 | 2011 | 20 | 0.090 |
Why?
|
Gene Frequency | 4 | 2015 | 3624 | 0.090 |
Why?
|
Cholesterol, HDL | 2 | 2023 | 1814 | 0.090 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12064 | 0.090 |
Why?
|
Athletes | 1 | 2019 | 1161 | 0.090 |
Why?
|
Calcium | 1 | 2024 | 5783 | 0.090 |
Why?
|
Sweden | 2 | 2024 | 1382 | 0.090 |
Why?
|
Dairy Products | 1 | 2014 | 490 | 0.090 |
Why?
|
Chromosome Mapping | 1 | 2019 | 4618 | 0.090 |
Why?
|
Mesencephalon | 1 | 2013 | 337 | 0.090 |
Why?
|
Psychological Tests | 1 | 2013 | 642 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3360 | 0.090 |
Why?
|
Frontotemporal Dementia | 1 | 2014 | 249 | 0.090 |
Why?
|
Retinal Diseases | 1 | 2017 | 709 | 0.090 |
Why?
|
Dopamine beta-Hydroxylase | 1 | 2010 | 74 | 0.090 |
Why?
|
Retrospective Studies | 6 | 2016 | 81657 | 0.090 |
Why?
|
RNA Interference | 1 | 2019 | 2829 | 0.090 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1251 | 0.090 |
Why?
|
Principal Component Analysis | 1 | 2014 | 949 | 0.090 |
Why?
|
Serine Endopeptidases | 1 | 2016 | 1027 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3230 | 0.090 |
Why?
|
Patient Selection | 1 | 2022 | 4252 | 0.090 |
Why?
|
Child | 6 | 2024 | 80670 | 0.090 |
Why?
|
Primary Prevention | 1 | 2018 | 1188 | 0.090 |
Why?
|
Algorithms | 4 | 2019 | 14073 | 0.090 |
Why?
|
Plaque, Amyloid | 1 | 2014 | 769 | 0.090 |
Why?
|
Electrocardiography | 4 | 2024 | 6408 | 0.090 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1730 | 0.090 |
Why?
|
Triglycerides | 2 | 2023 | 2441 | 0.090 |
Why?
|
ABO Blood-Group System | 1 | 2013 | 381 | 0.090 |
Why?
|
Basal Ganglia | 1 | 2013 | 549 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2024 | 9528 | 0.080 |
Why?
|
Fibrinogen | 1 | 2013 | 893 | 0.080 |
Why?
|
Forced Expiratory Volume | 1 | 2015 | 1828 | 0.080 |
Why?
|
Chromosomes, Human, X | 1 | 2011 | 319 | 0.080 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 281 | 0.080 |
Why?
|
Survival Rate | 3 | 2015 | 12826 | 0.080 |
Why?
|
Transferrin | 1 | 2010 | 283 | 0.080 |
Why?
|
Germany | 1 | 2011 | 882 | 0.080 |
Why?
|
Glycoproteins | 1 | 2017 | 2201 | 0.080 |
Why?
|
Genomics | 3 | 2024 | 5922 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13489 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2015 | 1120 | 0.080 |
Why?
|
Frail Elderly | 1 | 2014 | 781 | 0.080 |
Why?
|
Neurons | 2 | 2010 | 9515 | 0.080 |
Why?
|
Cholesterol, LDL | 2 | 2023 | 2392 | 0.080 |
Why?
|
Epigenomics | 2 | 2024 | 958 | 0.080 |
Why?
|
Pattern Recognition, Automated | 1 | 2014 | 980 | 0.080 |
Why?
|
Medical Audit | 1 | 2010 | 454 | 0.080 |
Why?
|
Neural Pathways | 1 | 2019 | 3079 | 0.080 |
Why?
|
Logistic Models | 2 | 2014 | 13276 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3269 | 0.080 |
Why?
|
Iron Overload | 1 | 2010 | 245 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2921 | 0.070 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2008 | 98 | 0.070 |
Why?
|
Adolescent | 7 | 2024 | 88902 | 0.070 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 792 | 0.070 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2011 | 566 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2018 | 2631 | 0.070 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2019 | 1882 | 0.070 |
Why?
|
Analysis of Variance | 1 | 2016 | 6214 | 0.070 |
Why?
|
Reaction Time | 1 | 2014 | 2085 | 0.070 |
Why?
|
Arthritis | 1 | 2012 | 684 | 0.070 |
Why?
|
Liver | 1 | 2023 | 7571 | 0.070 |
Why?
|
Dyspnea | 1 | 2015 | 1352 | 0.070 |
Why?
|
Asia | 2 | 2023 | 629 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2614 | 0.070 |
Why?
|
Hand Strength | 2 | 2024 | 466 | 0.070 |
Why?
|
Oxidative Stress | 2 | 2015 | 3139 | 0.070 |
Why?
|
Metabolome | 2 | 2024 | 1008 | 0.070 |
Why?
|
Blood Coagulation | 1 | 2013 | 1163 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6329 | 0.070 |
Why?
|
Cerebral Veins | 1 | 2007 | 157 | 0.070 |
Why?
|
Receptors, Immunologic | 1 | 2012 | 1417 | 0.070 |
Why?
|
Animals | 6 | 2023 | 168939 | 0.070 |
Why?
|
Fasting | 1 | 2012 | 1609 | 0.070 |
Why?
|
Reference Values | 1 | 2013 | 4914 | 0.060 |
Why?
|
Pregnancy | 3 | 2024 | 30236 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4810 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2024 | 11924 | 0.060 |
Why?
|
Haplotypes | 1 | 2012 | 2726 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3321 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1326 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15564 | 0.060 |
Why?
|
Receptors, Androgen | 1 | 2011 | 1089 | 0.060 |
Why?
|
Cerebrospinal Fluid | 1 | 2008 | 540 | 0.060 |
Why?
|
Adipose Tissue | 1 | 2017 | 3317 | 0.060 |
Why?
|
Models, Genetic | 1 | 2015 | 3446 | 0.060 |
Why?
|
Poland | 1 | 2024 | 197 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2649 | 0.060 |
Why?
|
Acetone | 1 | 2024 | 44 | 0.060 |
Why?
|
Olfactory Mucosa | 1 | 2024 | 101 | 0.060 |
Why?
|
Social Support | 2 | 2024 | 2191 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14653 | 0.060 |
Why?
|
Child, Preschool | 3 | 2024 | 42577 | 0.060 |
Why?
|
Overweight | 1 | 2015 | 2447 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2018 | 3235 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2019 | 14473 | 0.060 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2010 | 1362 | 0.060 |
Why?
|
Coronary Angiography | 1 | 2015 | 4525 | 0.060 |
Why?
|
Hippurates | 1 | 2023 | 15 | 0.060 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2024 | 75 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8507 | 0.050 |
Why?
|
Gene Expression | 1 | 2016 | 7585 | 0.050 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4114 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2012 | 2591 | 0.050 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 79 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3771 | 0.050 |
Why?
|
Models, Biological | 1 | 2019 | 9464 | 0.050 |
Why?
|
England | 1 | 2024 | 533 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2016 | 3078 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3431 | 0.050 |
Why?
|
Health Surveys | 1 | 2012 | 4055 | 0.050 |
Why?
|
E-Selectin | 1 | 2024 | 576 | 0.050 |
Why?
|
Peripheral Nervous System | 1 | 2023 | 151 | 0.050 |
Why?
|
Choline | 1 | 2024 | 511 | 0.050 |
Why?
|
Heart Rate | 2 | 2024 | 4207 | 0.050 |
Why?
|
Selection Bias | 1 | 2024 | 359 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2024 | 692 | 0.050 |
Why?
|
Blood Cells | 1 | 2024 | 309 | 0.050 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 382 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3702 | 0.050 |
Why?
|
Iceland | 2 | 2012 | 183 | 0.050 |
Why?
|
Loneliness | 1 | 2024 | 211 | 0.050 |
Why?
|
Ruminococcus | 1 | 2021 | 11 | 0.050 |
Why?
|
Endothelial Cells | 2 | 2024 | 3582 | 0.050 |
Why?
|
Computers | 1 | 2023 | 589 | 0.050 |
Why?
|
Cardiotonic Agents | 1 | 2024 | 541 | 0.050 |
Why?
|
Transcription Factors | 2 | 2023 | 12159 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5795 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2024 | 1131 | 0.040 |
Why?
|
Young Adult | 5 | 2024 | 59939 | 0.040 |
Why?
|
Antigens, CD | 1 | 2011 | 4033 | 0.040 |
Why?
|
Kidney | 2 | 2023 | 7073 | 0.040 |
Why?
|
Vitamin A | 1 | 2023 | 611 | 0.040 |
Why?
|
Developing Countries | 1 | 2013 | 2912 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.040 |
Why?
|
Disease Models, Animal | 1 | 2019 | 18329 | 0.040 |
Why?
|
Child Behavior Disorders | 1 | 2024 | 812 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1208 | 0.040 |
Why?
|
Long QT Syndrome | 1 | 2024 | 473 | 0.040 |
Why?
|
Muscle Strength | 1 | 2024 | 639 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2024 | 800 | 0.040 |
Why?
|
Lipoproteins | 1 | 2024 | 871 | 0.040 |
Why?
|
Quality Control | 1 | 2022 | 834 | 0.040 |
Why?
|
Skull | 1 | 2023 | 819 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2023 | 1527 | 0.040 |
Why?
|
Probability | 1 | 2024 | 2476 | 0.040 |
Why?
|
Amyloid | 1 | 2023 | 849 | 0.040 |
Why?
|
Face | 1 | 2024 | 1029 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9613 | 0.040 |
Why?
|
DNA | 1 | 2011 | 7210 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2024 | 1350 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2024 | 2721 | 0.040 |
Why?
|
Memory, Short-Term | 1 | 2024 | 1004 | 0.030 |
Why?
|
Metagenome | 1 | 2021 | 464 | 0.030 |
Why?
|
Adipocytes | 1 | 2024 | 1196 | 0.030 |
Why?
|
Asthma | 1 | 2016 | 6266 | 0.030 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 975 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 1044 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2021 | 550 | 0.030 |
Why?
|
Mice | 2 | 2023 | 81898 | 0.030 |
Why?
|
Hypnotics and Sedatives | 1 | 2024 | 1193 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2012 | 1996 | 0.030 |
Why?
|
Stroop Test | 1 | 2015 | 72 | 0.030 |
Why?
|
DNA, Intergenic | 1 | 2016 | 108 | 0.030 |
Why?
|
Cultured Milk Products | 1 | 2014 | 8 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2016 | 275 | 0.030 |
Why?
|
Databases, Genetic | 2 | 2012 | 1756 | 0.030 |
Why?
|
Heart | 1 | 2008 | 4425 | 0.030 |
Why?
|
United States | 1 | 2022 | 72945 | 0.030 |
Why?
|
Infant | 2 | 2018 | 36459 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2024 | 2257 | 0.030 |
Why?
|
Hemodynamics | 1 | 2024 | 4188 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 360 | 0.030 |
Why?
|
Russia | 1 | 2014 | 383 | 0.030 |
Why?
|
Computer Simulation | 2 | 2019 | 6258 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 3681 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2016 | 408 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2017 | 636 | 0.030 |
Why?
|
Family Health | 1 | 2018 | 1254 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 13476 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2020 | 935 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1960 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2024 | 2535 | 0.030 |
Why?
|
Peripheral Arterial Disease | 1 | 2024 | 1304 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2535 | 0.020 |
Why?
|
Calibration | 1 | 2014 | 814 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2014 | 328 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2024 | 10745 | 0.020 |
Why?
|
Chromatin | 1 | 2024 | 2980 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2024 | 3079 | 0.020 |
Why?
|
Chaperonins | 1 | 2011 | 58 | 0.020 |
Why?
|
International Cooperation | 1 | 2018 | 1434 | 0.020 |
Why?
|
Milk | 1 | 2014 | 436 | 0.020 |
Why?
|
Zebrafish | 1 | 2023 | 3035 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4340 | 0.020 |
Why?
|
Life Style | 1 | 2023 | 3926 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2014 | 412 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2474 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2010 | 88 | 0.020 |
Why?
|
Thrombosis | 1 | 2024 | 2953 | 0.020 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2011 | 199 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2024 | 2971 | 0.020 |
Why?
|
Iron Chelating Agents | 1 | 2010 | 141 | 0.020 |
Why?
|
Spain | 1 | 2010 | 483 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 3724 | 0.020 |
Why?
|
Africa | 1 | 2011 | 725 | 0.020 |
Why?
|
Locus Coeruleus | 1 | 2010 | 241 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5388 | 0.020 |
Why?
|
Multigene Family | 1 | 2011 | 1081 | 0.020 |
Why?
|
Movement Disorders | 1 | 2011 | 462 | 0.020 |
Why?
|
Fatigue | 1 | 2014 | 1555 | 0.020 |
Why?
|
Adiposity | 1 | 2017 | 1892 | 0.020 |
Why?
|
Heterozygote | 1 | 2012 | 2795 | 0.020 |
Why?
|
Nutritional Status | 1 | 2014 | 1621 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2011 | 1181 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6853 | 0.020 |
Why?
|
Mental Disorders | 1 | 2024 | 6869 | 0.010 |
Why?
|
Weight Loss | 1 | 2014 | 2712 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1885 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4780 | 0.010 |
Why?
|
Obesity | 1 | 2024 | 13090 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23618 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2010 | 3226 | 0.010 |
Why?
|
Venous Thromboembolism | 1 | 2013 | 1883 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26387 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8065 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3591 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2011 | 12795 | 0.010 |
Why?
|